A new study has uncovered that a gene variant common in Oceanian communities was misclassified as a potential cause of heart ...

Patients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment with high-dose anthracycline chemotherapy did not show any difference in troponin T levels ...

The enzymes troponin I and troponin T are normal proteins that are important in the contractile apparatus of the cardiac myocyte. The proteins are released into the circulation between 3 and 4 ...

Troponin is shown in red (subunits not distinguished). Upon binding calcium, troponin moves tropomyosin away from the myosin-binding sites on actin (bottom), effectively unblocking it. Modified ...

These findings come ... For patients with rheumatoid arthritis (RA), a detectable level of high-sensitivity cardiac troponin T (hs-cTnT) is associated with increased risk of major adverse ...

Results were collected and recorded on 156 patients over eight months from January to September 2003. This represented 85% of 184 eligible patients. Twenty-eight (15%) patients were excluded ...

ASO delivery and efficacy was first optimized by targeting cardiac troponin T in cardiac iPS-derived organoids: loss of rhythmic contraction in more than 90% of transfected organoids was achieved.

The rate of cardiac injury as determined by cTnI in this study was 19%. In trying to identify any factors that may contribute to an overestimation of cardiac injury, we consider the use of cTnI ...